Return On Assets in % of Processa Pharmaceuticals, Inc. from Q1 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Processa Pharmaceuticals, Inc. quarterly and annual Return On Assets history and change rate from Q1 2014 to Q3 2025.
  • Processa Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -217%, a 33% decline year-over-year.
  • Processa Pharmaceuticals, Inc. annual Return On Assets for 2024 was -184%, a 51% decline from 2023.
  • Processa Pharmaceuticals, Inc. annual Return On Assets for 2023 was -122%, a 18% increase from 2022.
  • Processa Pharmaceuticals, Inc. annual Return On Assets for 2022 was -150%, a 293% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Processa Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -217% -54% -33% 01 Jul 2025 30 Sep 2025
Q2 2025 -243% -113% -87% 01 Apr 2025 30 Jun 2025
Q1 2025 -232% -116% -100% 01 Jan 2025 31 Mar 2025
Q4 2024 -184% -62% -51% 01 Oct 2024 31 Dec 2024
Q3 2024 -163% +59% +26% 01 Jul 2024 30 Sep 2024
Q2 2024 -130% +76% +37% 01 Apr 2024 30 Jun 2024
Q1 2024 -116% +68% +37% 01 Jan 2024 31 Mar 2024
Q4 2023 -122% +28% +18% 01 Oct 2023 31 Dec 2023
Q3 2023 -222% -144% -187% 01 Jul 2023 30 Sep 2023
Q2 2023 -206% -149% -259% 01 Apr 2023 30 Jun 2023
Q1 2023 -184% -139% -307% 01 Jan 2023 31 Mar 2023
Q4 2022 -150% -112% -293% 01 Oct 2022 31 Dec 2022
Q3 2022 -77% -17% -28% 01 Jul 2022 30 Sep 2022
Q2 2022 -57% +15% +21% 01 Apr 2022 30 Jun 2022
Q1 2022 -45% +35% +43% 01 Jan 2022 31 Mar 2022
Q4 2021 -38% +67% +64% 01 Oct 2021 31 Dec 2021
Q3 2021 -61% -6.7% -12% 01 Jul 2021 30 Sep 2021
Q2 2021 -73% -42% -134% 01 Apr 2021 30 Jun 2021
Q1 2021 -80% -48% -147% 01 Jan 2021 31 Mar 2021
Q4 2020 -105% -75% -253% 01 Oct 2020 31 Dec 2020
Q3 2020 -54% -27% -97% 01 Jul 2020 30 Sep 2020
Q2 2020 -31% -5.3% -21% 01 Apr 2020 30 Jun 2020
Q1 2020 -32% -6.3% -24% 01 Jan 2020 31 Mar 2020
Q4 2019 -30% -1.5% -5.4% 01 Oct 2019 31 Dec 2019
Q3 2019 -27% +7.3% +21% 01 Jul 2019 30 Sep 2019
Q2 2019 -26% +22% +46% 01 Apr 2019 30 Jun 2019
Q1 2019 -26% +42% +62% 01 Jan 2019 31 Mar 2019
Q4 2018 -28% +214% +88% 01 Oct 2018 31 Dec 2018
Q3 2018 -35% +203% +85% 01 Jul 2018 30 Sep 2018
Q2 2018 -48% +214% +82% 01 Apr 2018 30 Jun 2018
Q1 2018 -68% +237% +78% 01 Jan 2018 31 Mar 2018
Q4 2017 -242% +66% +21% 01 Oct 2017 31 Dec 2017
Q3 2017 -238% +3313% +93% 01 Jul 2017 30 Sep 2017
Q2 2017 -262% +612% +70% 01 Apr 2017 30 Jun 2017
Q1 2017 -306% +477% +61% 01 Jan 2017 31 Mar 2017
Q4 2016 -308% +26% +7.7% 01 Oct 2016 31 Dec 2016
Q3 2016 -3551% -3271% -1167% 01 Jul 2016 30 Sep 2016
Q2 2016 -873% -641% -275% 01 Apr 2016 30 Jun 2016
Q1 2016 -783% -638% -439% 01 Jan 2016 31 Mar 2016
Q4 2015 -333% -167% -101% 01 Oct 2015 31 Dec 2015
Q3 2015 -280% -146% -109% 01 Jul 2015 30 Sep 2015
Q2 2015 -233% -114% -95% 01 Apr 2015 30 Jun 2015
Q1 2015 -145% -36% -33% 01 Jan 2015 31 Mar 2015
Q4 2014 -166% 01 Oct 2014 31 Dec 2014
Q3 2014 -134% 01 Jul 2014 30 Sep 2014
Q2 2014 -119% 01 Apr 2014 30 Jun 2014
Q1 2014 -109% 01 Jan 2014 31 Mar 2014

Processa Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -184% -62% -51% 01 Jan 2024 31 Dec 2024
2023 -122% +28% +18% 01 Jan 2023 31 Dec 2023
2022 -150% -112% -293% 01 Jan 2022 31 Dec 2022
2021 -38% +67% +64% 01 Jan 2021 31 Dec 2021
2020 -105% -75% -253% 01 Jan 2020 31 Dec 2020
2019 -30% -1.5% -5.4% 01 Jan 2019 31 Dec 2019
2018 -28% +214% +88% 01 Jan 2018 31 Dec 2018
2017 -242% +66% +21% 01 Jan 2017 31 Dec 2017
2016 -308% +26% +7.7% 01 Jan 2016 31 Dec 2016
2015 -333% -167% -101% 01 Jan 2015 31 Dec 2015
2014 -166% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.